Bank Of Nova Scotia Fulgent Genetics, Inc. Transaction History

Bank Of Nova Scotia

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$77.3 - $105.0 $2.66 Million - $3.61 Million	-34,414 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $1.29 Million - $1.91 Million	-17,272 Reduced 33.42%	34,414 $3.08 Million
Q2 2021 Aug 12, 2021	BUY	$66.8 - $100.45 $3.45 Million - $5.19 Million	51,686 New	51,686 $4.76 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $524M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.